🔎 Trials Near Me

Gara Jalqabaatti › Kansara Neuroendocrine › Missouri › St. Louis

Qorannoo klinikaalii Kansara Neuroendocrine St. Louis, MO keessatti

Qorannoo 3 Kansara Neuroendocrine f St. Louis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

Namoota walitti qabaa jiraSadarkaa 1
  • Washington University Medicine, St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT07488923

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Washington University School of Medicine (Siteman Cancer Center), St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ado-2026 · NCT05652686

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Namoota walitti qabaa jiraSadarkaa 1/2
  • Washington University Infusion Center Pharmacy, St Louis
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT03093116

Qorannoo Kansara Neuroendocrine magaalota biroo keessatti

Qorannoo biroo St. Louis keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.